ICOSAPENT ETHYL (has an active metabolite) | ICOSAPENT ETHYL | CARDIOVASCULAR ADJUNCT TO DIET TO REDUCE TRIGLYCERIDE (TG) LEVELS IN ADULT PATIENTS WITH SEVERE (>= 500 MG/DL) HYPERTRIGLYCERIDEMIA POTENTIAL MECHANISMS OF ACTION INCLUDE INCREASED BETA-OXIDATION INHIBITION OF ACYL-COA:1,2-DIACYLGLYCEROL ACYLTRANSFERASE (DGAT) DECREASED LIPOGENESIS IN THE LIVER AND INCREASED PLASMA LIPOPROTEIN LIPASE ACTIVITY | ORAL | | | DIACYLGLYCEROL O-ACYLTRANSFERASE 1 O75907 DIACYLGLYCEROL O-ACYLTRANSFERASE 1 HOMO SAPIENS ENZYME | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |